{
  "170520_MM64_03.raw": {
    "Source Name": [
      "MM64"
    ],
    "Assay Name": [
      "170520_MM64_03"
    ],
    "Raw Data File": [
      "170520_MM64_03.raw"
    ],
    "Characteristics[NumberOfSamples]": [
      "111 lymph node metastasis samples from patients with malignant melanoma (Stage 3 and 4), archived in the local malignant melanoma biobank were obtained from Skåne University Hospital, Sweden."
    ],
    "Characteristics[Specimen]": [
      "Frozen tissue samples from BD20 were sectioned on a cryostat into 10\u2009\u00b5m thick slices (approximately 6\u00d76\u2009mm), placed into a 96 well plate and stored at \u221280\u2009\u00b0C until further use."
    ],
    "Characteristics[MaterialType]": [
      "Frozen specimens (snap frozen immediately after surgery)"
    ],
    "Characteristics[Disease]": [
      "malignant melanoma"
    ],
    "Characteristics[SpikedCompound]": [
      "The samples were spiked with 0.1\u2009mg of internal standard \u2013 chicken lysozyme (CL, Swiss-Prot accession no. P00698).",
      "20\u2009\u00b5L of samples were mixed with 20\u2009\u00b5L of peptide retention time calibration mixture (PRTC, Pierce/Thermo Scientific, Rockford, IL, 20 fmoL/mL)."
    ],
    "Characteristics[CleavageAgent]": [
      "sequencing grade trypsin (Promega, Madison, WI)"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "50\u2009mM iodoacetamide"
    ],
    "Comment[Instrument]": [
      "Thermo Easy nLC 1000 system (Thermo Fisher Scientific)",
      "Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)"
    ],
    "Comment[Separation]": [
      "Online chromatography was performed with a Thermo Easy nLC 1000 system (Thermo Fisher Scientific) coupled online to a Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)."
    ],
    "Comment[FlowRateChromatogram]": [
      "Flow rate of 300 nL/min and a column temperature of 35\u2009\u00b0C were utilised."
    ],
    "Comment[GradientTime]": [
      "the gradient went from 5% to 40% B in the first 120\u2009min"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent top-15 method"
    ],
    "Comment[FragmentationMethod]": [
      "fragmented in the HCD collision cell"
    ],
    "Comment[CollisionEnergy]": [
      "normalised collision energy of 30%"
    ],
    "Comment[MS2MassAnalyzer]": [
      "tandem mass spectra were acquired in the Orbitrap mass analyzer with resolution of 17 500 (at m/z 200), target AGC value of 1\u2212106 and maximum injection time of 120\u2009ms."
    ],
    "Comment[PrecursorMassTolerance]": [
      "20 ppm precursor tolerance"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02\u2009Da fragment tolerance"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "Up to two missed cleavages for tryptic peptides was allowed."
    ],
    "Comment[Instrument]": [
      "Thermo Easy nLC 1000 system (Thermo Fisher Scientific)",
      "Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)"
    ],
    "Characteristics[Label]": [
      "Label-free LC-MS/MS analysis"
    ]
  },
  "160629_MM_31_03.raw": {
    "Source Name": [
      "MM_31"
    ],
    "Assay Name": [
      "160629_MM_31_03"
    ],
    "Raw Data File": [
      "160629_MM_31_03.raw"
    ],
    "Characteristics[NumberOfSamples]": [
      "111 lymph node metastasis samples from patients with malignant melanoma (Stage 3 and 4), archived in the local malignant melanoma biobank were obtained from Skåne University Hospital, Sweden."
    ],
    "Characteristics[Specimen]": [
      "Frozen tissue samples from BD20 were sectioned on a cryostat into 10\u2009\u00b5m thick slices (approximately 6\u00d76\u2009mm), placed into a 96 well plate and stored at \u221280\u2009\u00b0C until further use."
    ],
    "Characteristics[MaterialType]": [
      "Frozen specimens (snap frozen immediately after surgery)"
    ],
    "Characteristics[Disease]": [
      "malignant melanoma"
    ],
    "Characteristics[SpikedCompound]": [
      "The samples were spiked with 0.1\u2009mg of internal standard \u2013 chicken lysozyme (CL, Swiss-Prot accession no. P00698).",
      "20\u2009\u00b5L of samples were mixed with 20\u2009\u00b5L of peptide retention time calibration mixture (PRTC, Pierce/Thermo Scientific, Rockford, IL, 20 fmoL/mL)."
    ],
    "Characteristics[CleavageAgent]": [
      "sequencing grade trypsin (Promega, Madison, WI)"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "50\u2009mM iodoacetamide"
    ],
    "Comment[Instrument]": [
      "Thermo Easy nLC 1000 system (Thermo Fisher Scientific)",
      "Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)"
    ],
    "Comment[Separation]": [
      "Online chromatography was performed with a Thermo Easy nLC 1000 system (Thermo Fisher Scientific) coupled online to a Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)."
    ],
    "Comment[FlowRateChromatogram]": [
      "Flow rate of 300 nL/min and a column temperature of 35\u2009\u00b0C were utilised."
    ],
    "Comment[GradientTime]": [
      "the gradient went from 5% to 40% B in the first 120\u2009min"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent top-15 method"
    ],
    "Comment[FragmentationMethod]": [
      "fragmented in the HCD collision cell"
    ],
    "Comment[CollisionEnergy]": [
      "normalised collision energy of 30%"
    ],
    "Comment[MS2MassAnalyzer]": [
      "tandem mass spectra were acquired in the Orbitrap mass analyzer with resolution of 17 500 (at m/z 200), target AGC value of 1\u2212106 and maximum injection time of 120\u2009ms."
    ],
    "Comment[PrecursorMassTolerance]": [
      "20 ppm precursor tolerance"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02\u2009Da fragment tolerance"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "Up to two missed cleavages for tryptic peptides was allowed."
    ],
    "Characteristics[Label]": [
      "Label-free LC-MS/MS analysis"
    ]
  },
  "170517_MM110_03.raw": {
    "Source Name": [
      "MM110"
    ],
    "Assay Name": [
      "170517_MM110_03"
    ],
    "Raw Data File": [
      "170517_MM110_03.raw"
    ],
    "Characteristics[NumberOfSamples]": [
      "111 lymph node metastasis samples from patients with malignant melanoma (Stage 3 and 4), archived in the local malignant melanoma biobank were obtained from Skåne University Hospital, Sweden."
    ],
    "Characteristics[Specimen]": [
      "Frozen tissue samples from BD20 were sectioned on a cryostat into 10\u2009\u00b5m thick slices (approximately 6\u00d76\u2009mm), placed into a 96 well plate and stored at \u221280\u2009\u00b0C until further use."
    ],
    "Characteristics[MaterialType]": [
      "Frozen specimens (snap frozen immediately after surgery)"
    ],
    "Characteristics[Disease]": [
      "malignant melanoma"
    ],
    "Characteristics[SpikedCompound]": [
      "The samples were spiked with 0.1\u2009mg of internal standard \u2013 chicken lysozyme (CL, Swiss-Prot accession no. P00698).",
      "20\u2009\u00b5L of samples were mixed with 20\u2009\u00b5L of peptide retention time calibration mixture (PRTC, Pierce/Thermo Scientific, Rockford, IL, 20 fmoL/mL)."
    ],
    "Characteristics[CleavageAgent]": [
      "sequencing grade trypsin (Promega, Madison, WI)"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "50\u2009mM iodoacetamide"
    ],
    "Comment[Instrument]": [
      "Thermo Easy nLC 1000 system (Thermo Fisher Scientific)",
      "Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)"
    ],
    "Comment[Separation]": [
      "Online chromatography was performed with a Thermo Easy nLC 1000 system (Thermo Fisher Scientific) coupled online to a Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)."
    ],
    "Comment[FlowRateChromatogram]": [
      "Flow rate of 300 nL/min and a column temperature of 35\u2009\u00b0C were utilised."
    ],
    "Comment[GradientTime]": [
      "the gradient went from 5% to 40% B in the first 120\u2009min"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent top-15 method"
    ],
    "Comment[FragmentationMethod]": [
      "fragmented in the HCD collision cell"
    ],
    "Comment[CollisionEnergy]": [
      "normalised collision energy of 30%"
    ],
    "Comment[MS2MassAnalyzer]": [
      "tandem mass spectra were acquired in the Orbitrap mass analyzer with resolution of 17 500 (at m/z 200), target AGC value of 1\u2212106 and maximum injection time of 120\u2009ms."
    ],
    "Comment[PrecursorMassTolerance]": [
      "20 ppm precursor tolerance"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02\u2009Da fragment tolerance"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "Up to two missed cleavages for tryptic peptides was allowed."
    ],
    "Characteristics[Label]": [
      "Label-free LC-MS/MS analysis"
    ]
  },
  "170522_MM87_04.raw": {
    "Source Name": [
      "MM87"
    ],
    "Assay Name": [
      "170522_MM87_04"
    ],
    "Raw Data File": [
      "170522_MM87_04.raw"
    ],
    "Characteristics[NumberOfSamples]": [
      "111 lymph node metastasis samples from patients with malignant melanoma (Stage 3 and 4), archived in the local malignant melanoma biobank were obtained from Skåne University Hospital, Sweden."
    ],
    "Characteristics[Specimen]": [
      "Frozen tissue samples from BD20 were sectioned on a cryostat into 10\u2009\u00b5m thick slices (approximately 6\u00d76\u2009mm), placed into a 96 well plate and stored at \u221280\u2009\u00b0C until further use."
    ],
    "Characteristics[MaterialType]": [
      "Frozen specimens (snap frozen immediately after surgery)"
    ],
    "Characteristics[Disease]": [
      "malignant melanoma"
    ],
    "Characteristics[SpikedCompound]": [
      "The samples were spiked with 0.1\u2009mg of internal standard \u2013 chicken lysozyme (CL, Swiss-Prot accession no. P00698).",
      "20\u2009\u00b5L of samples were mixed with 20\u2009\u00b5L of peptide retention time calibration mixture (PRTC, Pierce/Thermo Scientific, Rockford, IL, 20 fmoL/mL)."
    ],
    "Characteristics[CleavageAgent]": [
      "sequencing grade trypsin (Promega, Madison, WI)"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "50\u2009mM iodoacetamide"
    ],
    "Comment[Instrument]": [
      "Thermo Easy nLC 1000 system (Thermo Fisher Scientific)",
      "Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)"
    ],
    "Comment[Separation]": [
      "Online chromatography was performed with a Thermo Easy nLC 1000 system (Thermo Fisher Scientific) coupled online to a Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)."
    ],
    "Comment[FlowRateChromatogram]": [
      "Flow rate of 300 nL/min and a column temperature of 35\u2009\u00b0C were utilised."
    ],
    "Comment[GradientTime]": [
      "the gradient went from 5% to 40% B in the first 120\u2009min"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent top-15 method"
    ],
    "Comment[FragmentationMethod]": [
      "fragmented in the HCD collision cell"
    ],
    "Comment[CollisionEnergy]": [
      "normalised collision energy of 30%"
    ],
    "Comment[MS2MassAnalyzer]": [
      "tandem mass spectra were acquired in the Orbitrap mass analyzer with resolution of 17 500 (at m/z 200), target AGC value of 1\u2212106 and maximum injection time of 120\u2009ms."
    ],
    "Comment[PrecursorMassTolerance]": [
      "20 ppm precursor tolerance"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02\u2009Da fragment tolerance"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "Up to two missed cleavages for tryptic peptides was allowed."
    ],
    "Characteristics[Label]": [
      "Label-free LC-MS/MS analysis"
    ]
  },
  "170521_MM115_04.raw": {
    "Source Name": [
      "MM115"
    ],
    "Assay Name": [
      "170521_MM115_04"
    ],
    "Raw Data File": [
      "170521_MM115_04.raw"
    ],
    "Characteristics[NumberOfSamples]": [
      "111 lymph node metastasis samples from patients with malignant melanoma (Stage 3 and 4), archived in the local malignant melanoma biobank were obtained from Skåne University Hospital, Sweden."
    ],
    "Characteristics[Specimen]": [
      "Frozen tissue samples from BD20 were sectioned on a cryostat into 10\u2009\u00b5m thick slices (approximately 6\u00d76\u2009mm), placed into a 96 well plate and stored at \u221280\u2009\u00b0C until further use."
    ],
    "Characteristics[MaterialType]": [
      "Frozen specimens (snap frozen immediately after surgery)"
    ],
    "Characteristics[Disease]": [
      "malignant melanoma"
    ],
    "Characteristics[SpikedCompound]": [
      "The samples were spiked with 0.1\u2009mg of internal standard \u2013 chicken lysozyme (CL, Swiss-Prot accession no. P00698).",
      "20\u2009\u00b5L of samples were mixed with 20\u2009\u00b5L of peptide retention time calibration mixture (PRTC, Pierce/Thermo Scientific, Rockford, IL, 20 fmoL/mL)."
    ],
    "Characteristics[CleavageAgent]": [
      "sequencing grade trypsin (Promega, Madison, WI)"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "50\u2009mM iodoacetamide"
    ],
    "Comment[Instrument]": [
      "Thermo Easy nLC 1000 system (Thermo Fisher Scientific)",
      "Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)"
    ],
    "Comment[Separation]": [
      "Online chromatography was performed with a Thermo Easy nLC 1000 system (Thermo Fisher Scientific) coupled online to a Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)."
    ],
    "Comment[FlowRateChromatogram]": [
      "Flow rate of 300 nL/min and a column temperature of 35\u2009\u00b0C were utilised."
    ],
    "Comment[GradientTime]": [
      "the gradient went from 5% to 40% B in the first 120\u2009min"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent top-15 method"
    ],
    "Comment[FragmentationMethod]": [
      "fragmented in the HCD collision cell"
    ],
    "Comment[CollisionEnergy]": [
      "normalised collision energy of 30%"
    ],
    "Comment[MS2MassAnalyzer]": [
      "tandem mass spectra were acquired in the Orbitrap mass analyzer with resolution of 17 500 (at m/z 200), target AGC value of 1\u2212106 and maximum injection time of 120\u2009ms."
    ],
    "Comment[PrecursorMassTolerance]": [
      "20 ppm precursor tolerance"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02\u2009Da fragment tolerance"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "Up to two missed cleavages for tryptic peptides was allowed."
    ],
    "Characteristics[Label]": [
      "Label-free LC-MS/MS analysis"
    ]
  },
  "160629_MM_90_02.raw": {
    "Source Name": [
      "MM_90"
    ],
    "Assay Name": [
      "160629_MM_90_02"
    ],
    "Raw Data File": [
      "160629_MM_90_02.raw"
    ],
    "Characteristics[NumberOfSamples]": [
      "111 lymph node metastasis samples from patients with malignant melanoma (Stage 3 and 4), archived in the local malignant melanoma biobank were obtained from Skåne University Hospital, Sweden."
    ],
    "Characteristics[Specimen]": [
      "Frozen tissue samples from BD20 were sectioned on a cryostat into 10\u2009\u00b5m thick slices (approximately 6\u00d76\u2009mm), placed into a 96 well plate and stored at \u221280\u2009\u00b0C until further use."
    ],
    "Characteristics[MaterialType]": [
      "Frozen specimens (snap frozen immediately after surgery)"
    ],
    "Characteristics[Disease]": [
      "malignant melanoma"
    ],
    "Characteristics[SpikedCompound]": [
      "The samples were spiked with 0.1\u2009mg of internal standard \u2013 chicken lysozyme (CL, Swiss-Prot accession no. P00698).",
      "20\u2009\u00b5L of samples were mixed with 20\u2009\u00b5L of peptide retention time calibration mixture (PRTC, Pierce/Thermo Scientific, Rockford, IL, 20 fmoL/mL)."
    ],
    "Characteristics[CleavageAgent]": [
      "sequencing grade trypsin (Promega, Madison, WI)"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "50\u2009mM iodoacetamide"
    ],
    "Comment[Instrument]": [
      "Thermo Easy nLC 1000 system (Thermo Fisher Scientific)",
      "Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)"
    ],
    "Comment[Separation]": [
      "Online chromatography was performed with a Thermo Easy nLC 1000 system (Thermo Fisher Scientific) coupled online to a Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)."
    ],
    "Comment[FlowRateChromatogram]": [
      "Flow rate of 300 nL/min and a column temperature of 35\u2009\u00b0C were utilised."
    ],
    "Comment[GradientTime]": [
      "the gradient went from 5% to 40% B in the first 120\u2009min"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent top-15 method"
    ],
    "Comment[FragmentationMethod]": [
      "fragmented in the HCD collision cell"
    ],
    "Comment[CollisionEnergy]": [
      "normalised collision energy of 30%"
    ],
    "Comment[MS2MassAnalyzer]": [
      "tandem mass spectra were acquired in the Orbitrap mass analyzer with resolution of 17 500 (at m/z 200), target AGC value of 1\u2212106 and maximum injection time of 120\u2009ms."
    ],
    "Comment[PrecursorMassTolerance]": [
      "20 ppm precursor tolerance"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02\u2009Da fragment tolerance"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "Up to two missed cleavages for tryptic peptides was allowed."
    ],
    "Characteristics[Label]": [
      "Label-free LC-MS/MS analysis"
    ]
  },
  "160629_MM_16_03.raw": {
    "Source Name": [
      "MM_16"
    ],
    "Assay Name": [
      "160629_MM_16_03"
    ],
    "Raw Data File": [
      "160629_MM_16_03.raw"
    ],
    "Characteristics[NumberOfSamples]": [
      "111 lymph node metastasis samples from patients with malignant melanoma (Stage 3 and 4), archived in the local malignant melanoma biobank were obtained from Skåne University Hospital, Sweden."
    ],
    "Characteristics[Specimen]": [
      "Frozen tissue samples from BD20 were sectioned on a cryostat into 10\u2009\u00b5m thick slices (approximately 6\u00d76\u2009mm), placed into a 96 well plate and stored at \u221280\u2009\u00b0C until further use."
    ],
    "Characteristics[MaterialType]": [
      "Frozen specimens (snap frozen immediately after surgery)"
    ],
    "Characteristics[Disease]": [
      "malignant melanoma"
    ],
    "Characteristics[SpikedCompound]": [
      "The samples were spiked with 0.1\u2009mg of internal standard \u2013 chicken lysozyme (CL, Swiss-Prot accession no. P00698).",
      "20\u2009\u00b5L of samples were mixed with 20\u2009\u00b5L of peptide retention time calibration mixture (PRTC, Pierce/Thermo Scientific, Rockford, IL, 20 fmoL/mL)."
    ],
    "Characteristics[CleavageAgent]": [
      "sequencing grade trypsin (Promega, Madison, WI)"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "50\u2009mM iodoacetamide"
    ],
    "Comment[Instrument]": [
      "Thermo Easy nLC 1000 system (Thermo Fisher Scientific)",
      "Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)"
    ],
    "Comment[Separation]": [
      "Online chromatography was performed with a Thermo Easy nLC 1000 system (Thermo Fisher Scientific) coupled online to a Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)."
    ],
    "Comment[FlowRateChromatogram]": [
      "Flow rate of 300 nL/min and a column temperature of 35\u2009\u00b0C were utilised."
    ],
    "Comment[GradientTime]": [
      "the gradient went from 5% to 40% B in the first 120\u2009min"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent top-15 method"
    ],
    "Comment[FragmentationMethod]": [
      "fragmented in the HCD collision cell"
    ],
    "Comment[CollisionEnergy]": [
      "normalised collision energy of 30%"
    ],
    "Comment[MS2MassAnalyzer]": [
      "tandem mass spectra were acquired in the Orbitrap mass analyzer with resolution of 17 500 (at m/z 200), target AGC value of 1\u2212106 and maximum injection time of 120\u2009ms."
    ],
    "Comment[PrecursorMassTolerance]": [
      "20 ppm precursor tolerance"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02\u2009Da fragment tolerance"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "Up to two missed cleavages for tryptic peptides was allowed."
    ],
    "Characteristics[Label]": [
      "Label-free LC-MS/MS analysis"
    ]
  },
  "151106_MM_56_03.raw": {
    "Source Name": [
      "MM_56"
    ],
    "Assay Name": [
      "151106_MM_56_03"
    ],
    "Raw Data File": [
      "151106_MM_56_03.raw"
    ],
    "Characteristics[NumberOfSamples]": [
      "111 lymph node metastasis samples from patients with malignant melanoma (Stage 3 and 4), archived in the local malignant melanoma biobank were obtained from Skåne University Hospital, Sweden."
    ],
    "Characteristics[Specimen]": [
      "Frozen tissue samples from BD20 were sectioned on a cryostat into 10\u2009\u00b5m thick slices (approximately 6\u00d76\u2009mm), placed into a 96 well plate and stored at \u221280\u2009\u00b0C until further use."
    ],
    "Characteristics[MaterialType]": [
      "Frozen specimens (snap frozen immediately after surgery)"
    ],
    "Characteristics[Disease]": [
      "malignant melanoma"
    ],
    "Characteristics[SpikedCompound]": [
      "The samples were spiked with 0.1\u2009mg of internal standard \u2013 chicken lysozyme (CL, Swiss-Prot accession no. P00698).",
      "20\u2009\u00b5L of samples were mixed with 20\u2009\u00b5L of peptide retention time calibration mixture (PRTC, Pierce/Thermo Scientific, Rockford, IL, 20 fmoL/mL)."
    ],
    "Characteristics[CleavageAgent]": [
      "sequencing grade trypsin (Promega, Madison, WI)"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "50\u2009mM iodoacetamide"
    ],
    "Comment[Instrument]": [
      "Thermo Easy nLC 1000 system (Thermo Fisher Scientific)",
      "Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)"
    ],
    "Comment[Separation]": [
      "Online chromatography was performed with a Thermo Easy nLC 1000 system (Thermo Fisher Scientific) coupled online to a Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)."
    ],
    "Comment[FlowRateChromatogram]": [
      "Flow rate of 300 nL/min and a column temperature of 35\u2009\u00b0C were utilised."
    ],
    "Comment[GradientTime]": [
      "the gradient went from 5% to 40% B in the first 120\u2009min"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent top-15 method"
    ],
    "Comment[FragmentationMethod]": [
      "fragmented in the HCD collision cell"
    ],
    "Comment[CollisionEnergy]": [
      "normalised collision energy of 30%"
    ],
    "Comment[MS2MassAnalyzer]": [
      "tandem mass spectra were acquired in the Orbitrap mass analyzer with resolution of 17 500 (at m/z 200), target AGC value of 1\u2212106 and maximum injection time of 120\u2009ms."
    ],
    "Comment[PrecursorMassTolerance]": [
      "20 ppm precursor tolerance"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02\u2009Da fragment tolerance"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "Up to two missed cleavages for tryptic peptides was allowed."
    ],
    "Characteristics[Label]": [
      "Label-free LC-MS/MS analysis"
    ]
  },
  "151215_MM_78_02.raw": {
    "Source Name": [
      "MM_78"
    ],
    "Assay Name": [
      "151215_MM_78_02"
    ],
    "Raw Data File": [
      "151215_MM_78_02.raw"
    ],
    "Characteristics[NumberOfSamples]": [
      "111 lymph node metastasis samples from patients with malignant melanoma (Stage 3 and 4), archived in the local malignant melanoma biobank were obtained from Skåne University Hospital, Sweden."
    ],
    "Characteristics[Specimen]": [
      "Frozen tissue samples from BD20 were sectioned on a cryostat into 10\u2009\u00b5m thick slices (approximately 6\u00d76\u2009mm), placed into a 96 well plate and stored at \u221280\u2009\u00b0C until further use."
    ],
    "Characteristics[MaterialType]": [
      "Frozen specimens (snap frozen immediately after surgery)"
    ],
    "Characteristics[Disease]": [
      "malignant melanoma"
    ],
    "Characteristics[SpikedCompound]": [
      "The samples were spiked with 0.1\u2009mg of internal standard \u2013 chicken lysozyme (CL, Swiss-Prot accession no. P00698).",
      "20\u2009\u00b5L of samples were mixed with 20\u2009\u00b5L of peptide retention time calibration mixture (PRTC, Pierce/Thermo Scientific, Rockford, IL, 20 fmoL/mL)."
    ],
    "Characteristics[CleavageAgent]": [
      "sequencing grade trypsin (Promega, Madison, WI)"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "50\u2009mM iodoacetamide"
    ],
    "Comment[Instrument]": [
      "Thermo Easy nLC 1000 system (Thermo Fisher Scientific)",
      "Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)"
    ],
    "Comment[Separation]": [
      "Online chromatography was performed with a Thermo Easy nLC 1000 system (Thermo Fisher Scientific) coupled online to a Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)."
    ],
    "Comment[FlowRateChromatogram]": [
      "Flow rate of 300 nL/min and a column temperature of 35\u2009\u00b0C were utilised."
    ],
    "Comment[GradientTime]": [
      "the gradient went from 5% to 40% B in the first 120\u2009min"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent top-15 method"
    ],
    "Comment[FragmentationMethod]": [
      "fragmented in the HCD collision cell"
    ],
    "Comment[CollisionEnergy]": [
      "normalised collision energy of 30%"
    ],
    "Comment[MS2MassAnalyzer]": [
      "tandem mass spectra were acquired in the Orbitrap mass analyzer with resolution of 17 500 (at m/z 200), target AGC value of 1\u2212106 and maximum injection time of 120\u2009ms."
    ],
    "Comment[PrecursorMassTolerance]": [
      "20 ppm precursor tolerance"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02\u2009Da fragment tolerance"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "Up to two missed cleavages for tryptic peptides was allowed."
    ],
    "Characteristics[Label]": [
      "Label-free LC-MS/MS analysis"
    ]
  },
  "160629_MM_14_03.raw": {
    "Source Name": [
      "MM_14"
    ],
    "Assay Name": [
      "160629_MM_14_03"
    ],
    "Raw Data File": [
      "160629_MM_14_03.raw"
    ],
    "Characteristics[NumberOfSamples]": [
      "111 lymph node metastasis samples from patients with malignant melanoma (Stage 3 and 4), archived in the local malignant melanoma biobank were obtained from Skåne University Hospital, Sweden."
    ],
    "Characteristics[Specimen]": [
      "Frozen tissue samples from BD20 were sectioned on a cryostat into 10\u2009\u00b5m thick slices (approximately 6\u00d76\u2009mm), placed into a 96 well plate and stored at \u221280\u2009\u00b0C until further use."
    ],
    "Characteristics[MaterialType]": [
      "Frozen specimens (snap frozen immediately after surgery)"
    ],
    "Characteristics[Disease]": [
      "malignant melanoma"
    ],
    "Characteristics[SpikedCompound]": [
      "The samples were spiked with 0.1\u2009mg of internal standard \u2013 chicken lysozyme (CL, Swiss-Prot accession no. P00698).",
      "20\u2009\u00b5L of samples were mixed with 20\u2009\u00b5L of peptide retention time calibration mixture (PRTC, Pierce/Thermo Scientific, Rockford, IL, 20 fmoL/mL)."
    ],
    "Characteristics[CleavageAgent]": [
      "sequencing grade trypsin (Promega, Madison, WI)"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "50\u2009mM iodoacetamide"
    ],
    "Comment[Instrument]": [
      "Thermo Easy nLC 1000 system (Thermo Fisher Scientific)",
      "Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)"
    ],
    "Comment[Separation]": [
      "Online chromatography was performed with a Thermo Easy nLC 1000 system (Thermo Fisher Scientific) coupled online to a Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)."
    ],
    "Comment[FlowRateChromatogram]": [
      "Flow rate of 300 nL/min and a column temperature of 35\u2009\u00b0C were utilised."
    ],
    "Comment[GradientTime]": [
      "the gradient went from 5% to 40% B in the first 120\u2009min"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent top-15 method"
    ],
    "Comment[FragmentationMethod]": [
      "fragmented in the HCD collision cell"
    ],
    "Comment[CollisionEnergy]": [
      "normalised collision energy of 30%"
    ],
    "Comment[MS2MassAnalyzer]": [
      "tandem mass spectra were acquired in the Orbitrap mass analyzer with resolution of 17 500 (at m/z 200), target AGC value of 1\u2212106 and maximum injection time of 120\u2009ms."
    ],
    "Comment[PrecursorMassTolerance]": [
      "20 ppm precursor tolerance"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02\u2009Da fragment tolerance"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "Up to two missed cleavages for tryptic peptides was allowed."
    ],
    "Characteristics[Label]": [
      "Label-free LC-MS/MS analysis"
    ]
  },
  "170518_MM109_03.raw": {
    "Source Name": [
      "MM109"
    ],
    "Assay Name": [
      "170518_MM109_03"
    ],
    "Raw Data File": [
      "170518_MM109_03.raw"
    ],
    "Characteristics[NumberOfSamples]": [
      "111 lymph node metastasis samples from patients with malignant melanoma (Stage 3 and 4), archived in the local malignant melanoma biobank were obtained from Skåne University Hospital, Sweden."
    ],
    "Characteristics[Specimen]": [
      "Frozen tissue samples from BD20 were sectioned on a cryostat into 10\u2009\u00b5m thick slices (approximately 6\u00d76\u2009mm), placed into a 96 well plate and stored at \u221280\u2009\u00b0C until further use."
    ],
    "Characteristics[MaterialType]": [
      "Frozen specimens (snap frozen immediately after surgery)"
    ],
    "Characteristics[Disease]": [
      "malignant melanoma"
    ],
    "Characteristics[SpikedCompound]": [
      "The samples were spiked with 0.1\u2009mg of internal standard \u2013 chicken lysozyme (CL, Swiss-Prot accession no. P00698).",
      "20\u2009\u00b5L of samples were mixed with 20\u2009\u00b5L of peptide retention time calibration mixture (PRTC, Pierce/Thermo Scientific, Rockford, IL, 20 fmoL/mL)."
    ],
    "Characteristics[CleavageAgent]": [
      "sequencing grade trypsin (Promega, Madison, WI)"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "50\u2009mM iodoacetamide"
    ],
    "Comment[Instrument]": [
      "Thermo Easy nLC 1000 system (Thermo Fisher Scientific)",
      "Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)"
    ],
    "Comment[Separation]": [
      "Online chromatography was performed with a Thermo Easy nLC 1000 system (Thermo Fisher Scientific) coupled online to a Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)."
    ],
    "Comment[FlowRateChromatogram]": [
      "Flow rate of 300 nL/min and a column temperature of 35\u2009\u00b0C were utilised."
    ],
    "Comment[GradientTime]": [
      "the gradient went from 5% to 40% B in the first 120\u2009min"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent top-15 method"
    ],
    "Comment[FragmentationMethod]": [
      "fragmented in the HCD collision cell"
    ],
    "Comment[CollisionEnergy]": [
      "normalised collision energy of 30%"
    ],
    "Comment[MS2MassAnalyzer]": [
      "tandem mass spectra were acquired in the Orbitrap mass analyzer with resolution of 17 500 (at m/z 200), target AGC value of 1\u2212106 and maximum injection time of 120\u2009ms."
    ],
    "Comment[PrecursorMassTolerance]": [
      "20 ppm precursor tolerance"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02\u2009Da fragment tolerance"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "Up to two missed cleavages for tryptic peptides was allowed."
    ],
    "Characteristics[Label]": [
      "Label-free LC-MS/MS analysis"
    ]
  },
  "170520_MM93_03.raw": {
    "Source Name": [
      "MM93"
    ],
    "Assay Name": [
      "170520_MM93_03"
    ],
    "Raw Data File": [
      "170520_MM93_03.raw"
    ],
    "Characteristics[NumberOfSamples]": [
      "111 lymph node metastasis samples from patients with malignant melanoma (Stage 3 and 4), archived in the local malignant melanoma biobank were obtained from Skåne University Hospital, Sweden."
    ],
    "Characteristics[Specimen]": [
      "Frozen tissue samples from BD20 were sectioned on a cryostat into 10\u2009\u00b5m thick slices (approximately 6\u00d76\u2009mm), placed into a 96 well plate and stored at \u221280\u2009\u00b0C until further use."
    ],
    "Characteristics[MaterialType]": [
      "Frozen specimens (snap frozen immediately after surgery)"
    ],
    "Characteristics[Disease]": [
      "malignant melanoma"
    ],
    "Characteristics[SpikedCompound]": [
      "The samples were spiked with 0.1\u2009mg of internal standard \u2013 chicken lysozyme (CL, Swiss-Prot accession no. P00698).",
      "20\u2009\u00b5L of samples were mixed with 20\u2009\u00b5L of peptide retention time calibration mixture (PRTC, Pierce/Thermo Scientific, Rockford, IL, 20 fmoL/mL)."
    ],
    "Characteristics[CleavageAgent]": [
      "sequencing grade trypsin (Promega, Madison, WI)"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "50\u2009mM iodoacetamide"
    ],
    "Comment[Instrument]": [
      "Thermo Easy nLC 1000 system (Thermo Fisher Scientific)",
      "Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)"
    ],
    "Comment[Separation]": [
      "Online chromatography was performed with a Thermo Easy nLC 1000 system (Thermo Fisher Scientific) coupled online to a Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)."
    ],
    "Comment[FlowRateChromatogram]": [
      "Flow rate of 300 nL/min and a column temperature of 35\u2009\u00b0C were utilised."
    ],
    "Comment[GradientTime]": [
      "the gradient went from 5% to 40% B in the first 120\u2009min"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent top-15 method"
    ],
    "Comment[FragmentationMethod]": [
      "fragmented in the HCD collision cell"
    ],
    "Comment[CollisionEnergy]": [
      "normalised collision energy of 30%"
    ],
    "Comment[MS2MassAnalyzer]": [
      "tandem mass spectra were acquired in the Orbitrap mass analyzer with resolution of 17 500 (at m/z 200), target AGC value of 1\u2212106 and maximum injection time of 120\u2009ms."
    ],
    "Comment[PrecursorMassTolerance]": [
      "20 ppm precursor tolerance"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02\u2009Da fragment tolerance"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "Up to two missed cleavages for tryptic peptides was allowed."
    ],
    "Characteristics[Label]": [
      "Label-free LC-MS/MS analysis"
    ]
  },
  "160617_MM82_03.raw": {
    "Source Name": [
      "MM82"
    ],
    "Assay Name": [
      "160617_MM82_03"
    ],
    "Raw Data File": [
      "160617_MM82_03.raw"
    ],
    "Characteristics[NumberOfSamples]": [
      "111 lymph node metastasis samples from patients with malignant melanoma (Stage 3 and 4), archived in the local malignant melanoma biobank were obtained from Skåne University Hospital, Sweden."
    ],
    "Characteristics[Specimen]": [
      "Frozen tissue samples from BD20 were sectioned on a cryostat into 10\u2009\u00b5m thick slices (approximately 6\u00d76\u2009mm), placed into a 96 well plate and stored at \u221280\u2009\u00b0C until further use."
    ],
    "Characteristics[MaterialType]": [
      "Frozen specimens (snap frozen immediately after surgery)"
    ],
    "Characteristics[Disease]": [
      "malignant melanoma"
    ],
    "Characteristics[SpikedCompound]": [
      "The samples were spiked with 0.1\u2009mg of internal standard \u2013 chicken lysozyme (CL, Swiss-Prot accession no. P00698).",
      "20\u2009\u00b5L of samples were mixed with 20\u2009\u00b5L of peptide retention time calibration mixture (PRTC, Pierce/Thermo Scientific, Rockford, IL, 20 fmoL/mL)."
    ],
    "Characteristics[CleavageAgent]": [
      "sequencing grade trypsin (Promega, Madison, WI)"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "50\u2009mM iodoacetamide"
    ],
    "Comment[Instrument]": [
      "Thermo Easy nLC 1000 system (Thermo Fisher Scientific)",
      "Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)"
    ],
    "Comment[Separation]": [
      "Online chromatography was performed with a Thermo Easy nLC 1000 system (Thermo Fisher Scientific) coupled online to a Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)."
    ],
    "Comment[FlowRateChromatogram]": [
      "Flow rate of 300 nL/min and a column temperature of 35\u2009\u00b0C were utilised."
    ],
    "Comment[GradientTime]": [
      "the gradient went from 5% to 40% B in the first 120\u2009min"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent top-15 method"
    ],
    "Comment[FragmentationMethod]": [
      "fragmented in the HCD collision cell"
    ],
    "Comment[CollisionEnergy]": [
      "normalised collision energy of 30%"
    ],
    "Comment[MS2MassAnalyzer]": [
      "tandem mass spectra were acquired in the Orbitrap mass analyzer with resolution of 17 500 (at m/z 200), target AGC value of 1\u2212106 and maximum injection time of 120\u2009ms."
    ],
    "Comment[PrecursorMassTolerance]": [
      "20 ppm precursor tolerance"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02\u2009Da fragment tolerance"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "Up to two missed cleavages for tryptic peptides was allowed."
    ],
    "Characteristics[Label]": [
      "Label-free LC-MS/MS analysis"
    ]
  },
  "160622_MM68_02.raw": {
    "Source Name": [
      "MM68"
    ],
    "Assay Name": [
      "160622_MM68_02"
    ],
    "Raw Data File": [
      "160622_MM68_02.raw"
    ],
    "Characteristics[NumberOfSamples]": [
      "111 lymph node metastasis samples from patients with malignant melanoma (Stage 3 and 4), archived in the local malignant melanoma biobank were obtained from Skåne University Hospital, Sweden."
    ],
    "Characteristics[Specimen]": [
      "Frozen tissue samples from BD20 were sectioned on a cryostat into 10\u2009\u00b5m thick slices (approximately 6\u00d76\u2009mm), placed into a 96 well plate and stored at \u221280\u2009\u00b0C until further use."
    ],
    "Characteristics[MaterialType]": [
      "Frozen specimens (snap frozen immediately after surgery)"
    ],
    "Characteristics[Disease]": [
      "malignant melanoma"
    ],
    "Characteristics[SpikedCompound]": [
      "The samples were spiked with 0.1\u2009mg of internal standard \u2013 chicken lysozyme (CL, Swiss-Prot accession no. P00698).",
      "20\u2009\u00b5L of samples were mixed with 20\u2009\u00b5L of peptide retention time calibration mixture (PRTC, Pierce/Thermo Scientific, Rockford, IL, 20 fmoL/mL)."
    ],
    "Characteristics[CleavageAgent]": [
      "sequencing grade trypsin (Promega, Madison, WI)"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "50\u2009mM iodoacetamide"
    ],
    "Comment[Instrument]": [
      "Thermo Easy nLC 1000 system (Thermo Fisher Scientific)",
      "Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)"
    ],
    "Comment[Separation]": [
      "Online chromatography was performed with a Thermo Easy nLC 1000 system (Thermo Fisher Scientific) coupled online to a Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)."
    ],
    "Comment[FlowRateChromatogram]": [
      "Flow rate of 300 nL/min and a column temperature of 35\u2009\u00b0C were utilised."
    ],
    "Comment[GradientTime]": [
      "the gradient went from 5% to 40% B in the first 120\u2009min"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent top-15 method"
    ],
    "Comment[FragmentationMethod]": [
      "fragmented in the HCD collision cell"
    ],
    "Comment[CollisionEnergy]": [
      "normalised collision energy of 30%"
    ],
    "Comment[MS2MassAnalyzer]": [
      "tandem mass spectra were acquired in the Orbitrap mass analyzer with resolution of 17 500 (at m/z 200), target AGC value of 1\u2212106 and maximum injection time of 120\u2009ms."
    ],
    "Comment[PrecursorMassTolerance]": [
      "20 ppm precursor tolerance"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02\u2009Da fragment tolerance"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "Up to two missed cleavages for tryptic peptides was allowed."
    ],
    "Characteristics[Label]": [
      "Label-free LC-MS/MS analysis"
    ]
  },
  "160623_MM107_02.raw": {
    "Source Name": [
      "MM107"
    ],
    "Assay Name": [
      "160623_MM107_02"
    ],
    "Raw Data File": [
      "160623_MM107_02.raw"
    ],
    "Characteristics[NumberOfSamples]": [
      "111 lymph node metastasis samples from patients with malignant melanoma (Stage 3 and 4), archived in the local malignant melanoma biobank were obtained from Skåne University Hospital, Sweden."
    ],
    "Characteristics[Specimen]": [
      "Frozen tissue samples from BD20 were sectioned on a cryostat into 10\u2009\u00b5m thick slices (approximately 6\u00d76\u2009mm), placed into a 96 well plate and stored at \u221280\u2009\u00b0C until further use."
    ],
    "Characteristics[MaterialType]": [
      "Frozen specimens (snap frozen immediately after surgery)"
    ],
    "Characteristics[Disease]": [
      "malignant melanoma"
    ],
    "Characteristics[SpikedCompound]": [
      "The samples were spiked with 0.1\u2009mg of internal standard \u2013 chicken lysozyme (CL, Swiss-Prot accession no. P00698).",
      "20\u2009\u00b5L of samples were mixed with 20\u2009\u00b5L of peptide retention time calibration mixture (PRTC, Pierce/Thermo Scientific, Rockford, IL, 20 fmoL/mL)."
    ],
    "Characteristics[CleavageAgent]": [
      "sequencing grade trypsin (Promega, Madison, WI)"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "50\u2009mM iodoacetamide"
    ],
    "Comment[Instrument]": [
      "Thermo Easy nLC 1000 system (Thermo Fisher Scientific)",
      "Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)"
    ],
    "Comment[Separation]": [
      "Online chromatography was performed with a Thermo Easy nLC 1000 system (Thermo Fisher Scientific) coupled online to a Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)."
    ],
    "Comment[FlowRateChromatogram]": [
      "Flow rate of 300 nL/min and a column temperature of 35\u2009\u00b0C were utilised."
    ],
    "Comment[GradientTime]": [
      "the gradient went from 5% to 40% B in the first 120\u2009min"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent top-15 method"
    ],
    "Comment[FragmentationMethod]": [
      "fragmented in the HCD collision cell"
    ],
    "Comment[CollisionEnergy]": [
      "normalised collision energy of 30%"
    ],
    "Comment[MS2MassAnalyzer]": [
      "tandem mass spectra were acquired in the Orbitrap mass analyzer with resolution of 17 500 (at m/z 200), target AGC value of 1\u2212106 and maximum injection time of 120\u2009ms."
    ],
    "Comment[PrecursorMassTolerance]": [
      "20 ppm precursor tolerance"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02\u2009Da fragment tolerance"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "Up to two missed cleavages for tryptic peptides was allowed."
    ],
    "Characteristics[Label]": [
      "Label-free LC-MS/MS analysis"
    ]
  },
  "170519_MM103_03.raw": {
    "Source Name": [
      "MM103"
    ],
    "Assay Name": [
      "170519_MM103_03"
    ],
    "Raw Data File": [
      "170519_MM103_03.raw"
    ],
    "Characteristics[NumberOfSamples]": [
      "111 lymph node metastasis samples from patients with malignant melanoma (Stage 3 and 4), archived in the local malignant melanoma biobank were obtained from Skåne University Hospital, Sweden."
    ],
    "Characteristics[Specimen]": [
      "Frozen tissue samples from BD20 were sectioned on a cryostat into 10\u2009\u00b5m thick slices (approximately 6\u00d76\u2009mm), placed into a 96 well plate and stored at \u221280\u2009\u00b0C until further use."
    ],
    "Characteristics[MaterialType]": [
      "Frozen specimens (snap frozen immediately after surgery)"
    ],
    "Characteristics[Disease]": [
      "malignant melanoma"
    ],
    "Characteristics[SpikedCompound]": [
      "The samples were spiked with 0.1\u2009mg of internal standard \u2013 chicken lysozyme (CL, Swiss-Prot accession no. P00698).",
      "20\u2009\u00b5L of samples were mixed with 20\u2009\u00b5L of peptide retention time calibration mixture (PRTC, Pierce/Thermo Scientific, Rockford, IL, 20 fmoL/mL)."
    ],
    "Characteristics[CleavageAgent]": [
      "sequencing grade trypsin (Promega, Madison, WI)"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "50\u2009mM iodoacetamide"
    ],
    "Comment[Instrument]": [
      "Thermo Easy nLC 1000 system (Thermo Fisher Scientific)",
      "Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)"
    ],
    "Comment[Separation]": [
      "Online chromatography was performed with a Thermo Easy nLC 1000 system (Thermo Fisher Scientific) coupled online to a Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)."
    ],
    "Comment[FlowRateChromatogram]": [
      "Flow rate of 300 nL/min and a column temperature of 35\u2009\u00b0C were utilised."
    ],
    "Comment[GradientTime]": [
      "the gradient went from 5% to 40% B in the first 120\u2009min"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent top-15 method"
    ],
    "Comment[FragmentationMethod]": [
      "fragmented in the HCD collision cell"
    ],
    "Comment[CollisionEnergy]": [
      "normalised collision energy of 30%"
    ],
    "Comment[MS2MassAnalyzer]": [
      "tandem mass spectra were acquired in the Orbitrap mass analyzer with resolution of 17 500 (at m/z 200), target AGC value of 1\u2212106 and maximum injection time of 120\u2009ms."
    ],
    "Comment[PrecursorMassTolerance]": [
      "20 ppm precursor tolerance"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02\u2009Da fragment tolerance"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "Up to two missed cleavages for tryptic peptides was allowed."
    ],
    "Characteristics[Label]": [
      "Label-free LC-MS/MS analysis"
    ]
  },
  "MM91.raw": {
    "Source Name": [
      "MM91"
    ],
    "Assay Name": [
      "MM91"
    ],
    "Raw Data File": [
      "MM91.raw"
    ],
    "Characteristics[NumberOfSamples]": [
      "111 lymph node metastasis samples from patients with malignant melanoma (Stage 3 and 4), archived in the local malignant melanoma biobank were obtained from Skåne University Hospital, Sweden."
    ],
    "Characteristics[Specimen]": [
      "Frozen tissue samples from BD20 were sectioned on a cryostat into 10\u2009\u00b5m thick slices (approximately 6\u00d76\u2009mm), placed into a 96 well plate and stored at \u221280\u2009\u00b0C until further use."
    ],
    "Characteristics[MaterialType]": [
      "Frozen specimens (snap frozen immediately after surgery)"
    ],
    "Characteristics[Disease]": [
      "malignant melanoma"
    ],
    "Characteristics[SpikedCompound]": [
      "The samples were spiked with 0.1\u2009mg of internal standard \u2013 chicken lysozyme (CL, Swiss-Prot accession no. P00698).",
      "20\u2009\u00b5L of samples were mixed with 20\u2009\u00b5L of peptide retention time calibration mixture (PRTC, Pierce/Thermo Scientific, Rockford, IL, 20 fmoL/mL)."
    ],
    "Characteristics[CleavageAgent]": [
      "sequencing grade trypsin (Promega, Madison, WI)"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "50\u2009mM iodoacetamide"
    ],
    "Comment[Instrument]": [
      "Thermo Easy nLC 1000 system (Thermo Fisher Scientific)",
      "Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)"
    ],
    "Comment[Separation]": [
      "Online chromatography was performed with a Thermo Easy nLC 1000 system (Thermo Fisher Scientific) coupled online to a Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)."
    ],
    "Comment[FlowRateChromatogram]": [
      "Flow rate of 300 nL/min and a column temperature of 35\u2009\u00b0C were utilised."
    ],
    "Comment[GradientTime]": [
      "the gradient went from 5% to 40% B in the first 120\u2009min"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent top-15 method"
    ],
    "Comment[FragmentationMethod]": [
      "fragmented in the HCD collision cell"
    ],
    "Comment[CollisionEnergy]": [
      "normalised collision energy of 30%"
    ],
    "Comment[MS2MassAnalyzer]": [
      "tandem mass spectra were acquired in the Orbitrap mass analyzer with resolution of 17 500 (at m/z 200), target AGC value of 1\u2212106 and maximum injection time of 120\u2009ms."
    ],
    "Comment[PrecursorMassTolerance]": [
      "20 ppm precursor tolerance"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02\u2009Da fragment tolerance"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "Up to two missed cleavages for tryptic peptides was allowed."
    ],
    "Characteristics[Label]": [
      "Label-free LC-MS/MS analysis"
    ]
  },
  "151215_MM_81_02.raw": {
    "Source Name": [
      "MM_81"
    ],
    "Assay Name": [
      "151215_MM_81_02"
    ],
    "Raw Data File": [
      "151215_MM_81_02.raw"
    ],
    "Characteristics[NumberOfSamples]": [
      "111 lymph node metastasis samples from patients with malignant melanoma (Stage 3 and 4), archived in the local malignant melanoma biobank were obtained from Skåne University Hospital, Sweden."
    ],
    "Characteristics[Specimen]": [
      "Frozen tissue samples from BD20 were sectioned on a cryostat into 10\u2009\u00b5m thick slices (approximately 6\u00d76\u2009mm), placed into a 96 well plate and stored at \u221280\u2009\u00b0C until further use."
    ],
    "Characteristics[MaterialType]": [
      "Frozen specimens (snap frozen immediately after surgery)"
    ],
    "Characteristics[Disease]": [
      "malignant melanoma"
    ],
    "Characteristics[SpikedCompound]": [
      "The samples were spiked with 0.1\u2009mg of internal standard \u2013 chicken lysozyme (CL, Swiss-Prot accession no. P00698).",
      "20\u2009\u00b5L of samples were mixed with 20\u2009\u00b5L of peptide retention time calibration mixture (PRTC, Pierce/Thermo Scientific, Rockford, IL, 20 fmoL/mL)."
    ],
    "Characteristics[CleavageAgent]": [
      "sequencing grade trypsin (Promega, Madison, WI)"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "50\u2009mM iodoacetamide"
    ],
    "Comment[Instrument]": [
      "Thermo Easy nLC 1000 system (Thermo Fisher Scientific)",
      "Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)"
    ],
    "Comment[Separation]": [
      "Online chromatography was performed with a Thermo Easy nLC 1000 system (Thermo Fisher Scientific) coupled online to a Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)."
    ],
    "Comment[FlowRateChromatogram]": [
      "Flow rate of 300 nL/min and a column temperature of 35\u2009\u00b0C were utilised."
    ],
    "Comment[GradientTime]": [
      "the gradient went from 5% to 40% B in the first 120\u2009min"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent top-15 method"
    ],
    "Comment[FragmentationMethod]": [
      "fragmented in the HCD collision cell"
    ],
    "Comment[CollisionEnergy]": [
      "normalised collision energy of 30%"
    ],
    "Comment[MS2MassAnalyzer]": [
      "tandem mass spectra were acquired in the Orbitrap mass analyzer with resolution of 17 500 (at m/z 200), target AGC value of 1\u2212106 and maximum injection time of 120\u2009ms."
    ],
    "Comment[PrecursorMassTolerance]": [
      "20 ppm precursor tolerance"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02\u2009Da fragment tolerance"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "Up to two missed cleavages for tryptic peptides was allowed."
    ],
    "Characteristics[Label]": [
      "Label-free LC-MS/MS analysis"
    ]
  },
  "151215_MM_79_02.raw": {
    "Source Name": [
      "MM_79"
    ],
    "Assay Name": [
      "151215_MM_79_02"
    ],
    "Raw Data File": [
      "151215_MM_79_02.raw"
    ],
    "Characteristics[NumberOfSamples]": [
      "111 lymph node metastasis samples from patients with malignant melanoma (Stage 3 and 4), archived in the local malignant melanoma biobank were obtained from Skåne University Hospital, Sweden."
    ],
    "Characteristics[Specimen]": [
      "Frozen tissue samples from BD20 were sectioned on a cryostat into 10\u2009\u00b5m thick slices (approximately 6\u00d76\u2009mm), placed into a 96 well plate and stored at \u221280\u2009\u00b0C until further use."
    ],
    "Characteristics[MaterialType]": [
      "Frozen specimens (snap frozen immediately after surgery)"
    ],
    "Characteristics[Disease]": [
      "malignant melanoma"
    ],
    "Characteristics[SpikedCompound]": [
      "The samples were spiked with 0.1\u2009mg of internal standard \u2013 chicken lysozyme (CL, Swiss-Prot accession no. P00698).",
      "20\u2009\u00b5L of samples were mixed with 20\u2009\u00b5L of peptide retention time calibration mixture (PRTC, Pierce/Thermo Scientific, Rockford, IL, 20 fmoL/mL)."
    ],
    "Characteristics[CleavageAgent]": [
      "sequencing grade trypsin (Promega, Madison, WI)"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "50\u2009mM iodoacetamide"
    ],
    "Comment[Instrument]": [
      "Thermo Easy nLC 1000 system (Thermo Fisher Scientific)",
      "Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)"
    ],
    "Comment[Separation]": [
      "Online chromatography was performed with a Thermo Easy nLC 1000 system (Thermo Fisher Scientific) coupled online to a Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)."
    ],
    "Comment[FlowRateChromatogram]": [
      "Flow rate of 300 nL/min and a column temperature of 35\u2009\u00b0C were utilised."
    ],
    "Comment[GradientTime]": [
      "the gradient went from 5% to 40% B in the first 120\u2009min"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent top-15 method"
    ],
    "Comment[FragmentationMethod]": [
      "fragmented in the HCD collision cell"
    ],
    "Comment[CollisionEnergy]": [
      "normalised collision energy of 30%"
    ],
    "Comment[MS2MassAnalyzer]": [
      "tandem mass spectra were acquired in the Orbitrap mass analyzer with resolution of 17 500 (at m/z 200), target AGC value of 1\u2212106 and maximum injection time of 120\u2009ms."
    ],
    "Comment[PrecursorMassTolerance]": [
      "20 ppm precursor tolerance"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02\u2009Da fragment tolerance"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "Up to two missed cleavages for tryptic peptides was allowed."
    ],
    "Characteristics[Label]": [
      "Label-free LC-MS/MS analysis"
    ]
  },
  "160617_MM7_03.raw": {
    "Source Name": [
      "MM7"
    ],
    "Assay Name": [
      "160617_MM7_03"
    ],
    "Raw Data File": [
      "160617_MM7_03.raw"
    ],
    "Characteristics[NumberOfSamples]": [
      "111 lymph node metastasis samples from patients with malignant melanoma (Stage 3 and 4), archived in the local malignant melanoma biobank were obtained from Skåne University Hospital, Sweden."
    ],
    "Characteristics[Specimen]": [
      "Frozen tissue samples from BD20 were sectioned on a cryostat into 10\u2009\u00b5m thick slices (approximately 6\u00d76\u2009mm), placed into a 96 well plate and stored at \u221280\u2009\u00b0C until further use."
    ],
    "Characteristics[MaterialType]": [
      "Frozen specimens (snap frozen immediately after surgery)"
    ],
    "Characteristics[Disease]": [
      "malignant melanoma"
    ],
    "Characteristics[SpikedCompound]": [
      "The samples were spiked with 0.1\u2009mg of internal standard \u2013 chicken lysozyme (CL, Swiss-Prot accession no. P00698).",
      "20\u2009\u00b5L of samples were mixed with 20\u2009\u00b5L of peptide retention time calibration mixture (PRTC, Pierce/Thermo Scientific, Rockford, IL, 20 fmoL/mL)."
    ],
    "Characteristics[CleavageAgent]": [
      "sequencing grade trypsin (Promega, Madison, WI)"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "50\u2009mM iodoacetamide"
    ],
    "Comment[Instrument]": [
      "Thermo Easy nLC 1000 system (Thermo Fisher Scientific)",
      "Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)"
    ],
    "Comment[Separation]": [
      "Online chromatography was performed with a Thermo Easy nLC 1000 system (Thermo Fisher Scientific) coupled online to a Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)."
    ],
    "Comment[FlowRateChromatogram]": [
      "Flow rate of 300 nL/min and a column temperature of 35\u2009\u00b0C were utilised."
    ],
    "Comment[GradientTime]": [
      "the gradient went from 5% to 40% B in the first 120\u2009min"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent top-15 method"
    ],
    "Comment[FragmentationMethod]": [
      "fragmented in the HCD collision cell"
    ],
    "Comment[CollisionEnergy]": [
      "normalised collision energy of 30%"
    ],
    "Comment[MS2MassAnalyzer]": [
      "tandem mass spectra were acquired in the Orbitrap mass analyzer with resolution of 17 500 (at m/z 200), target AGC value of 1\u2212106 and maximum injection time of 120\u2009ms."
    ],
    "Comment[PrecursorMassTolerance]": [
      "20 ppm precursor tolerance"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02\u2009Da fragment tolerance"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "Up to two missed cleavages for tryptic peptides was allowed."
    ],
    "Characteristics[Label]": [
      "Label-free LC-MS/MS analysis"
    ]
  },
  "160629_MM_34_02.raw": {
    "Source Name": [
      "MM_34"
    ],
    "Assay Name": [
      "160629_MM_34_02"
    ],
    "Raw Data File": [
      "160629_MM_34_02.raw"
    ],
    "Characteristics[NumberOfSamples]": [
      "111 lymph node metastasis samples from patients with malignant melanoma (Stage 3 and 4), archived in the local malignant melanoma biobank were obtained from Skåne University Hospital, Sweden."
    ],
    "Characteristics[Specimen]": [
      "Frozen tissue samples from BD20 were sectioned on a cryostat into 10\u2009\u00b5m thick slices (approximately 6\u00d76\u2009mm), placed into a 96 well plate and stored at \u221280\u2009\u00b0C until further use."
    ],
    "Characteristics[MaterialType]": [
      "Frozen specimens (snap frozen immediately after surgery)"
    ],
    "Characteristics[Disease]": [
      "malignant melanoma"
    ],
    "Characteristics[SpikedCompound]": [
      "The samples were spiked with 0.1\u2009mg of internal standard \u2013 chicken lysozyme (CL, Swiss-Prot accession no. P00698).",
      "20\u2009\u00b5L of samples were mixed with 20\u2009\u00b5L of peptide retention time calibration mixture (PRTC, Pierce/Thermo Scientific, Rockford, IL, 20 fmoL/mL)."
    ],
    "Characteristics[CleavageAgent]": [
      "sequencing grade trypsin (Promega, Madison, WI)"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "50\u2009mM iodoacetamide"
    ],
    "Comment[Instrument]": [
      "Thermo Easy nLC 1000 system (Thermo Fisher Scientific)",
      "Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)"
    ],
    "Comment[Separation]": [
      "Online chromatography was performed with a Thermo Easy nLC 1000 system (Thermo Fisher Scientific) coupled online to a Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)."
    ],
    "Comment[FlowRateChromatogram]": [
      "Flow rate of 300 nL/min and a column temperature of 35\u2009\u00b0C were utilised."
    ],
    "Comment[GradientTime]": [
      "the gradient went from 5% to 40% B in the first 120\u2009min"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent top-15 method"
    ],
    "Comment[FragmentationMethod]": [
      "fragmented in the HCD collision cell"
    ],
    "Comment[CollisionEnergy]": [
      "normalised collision energy of 30%"
    ],
    "Comment[MS2MassAnalyzer]": [
      "tandem mass spectra were acquired in the Orbitrap mass analyzer with resolution of 17 500 (at m/z 200), target AGC value of 1\u2212106 and maximum injection time of 120\u2009ms."
    ],
    "Comment[PrecursorMassTolerance]": [
      "20 ppm precursor tolerance"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02\u2009Da fragment tolerance"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "Up to two missed cleavages for tryptic peptides was allowed."
    ],
    "Characteristics[Label]": [
      "Label-free LC-MS/MS analysis"
    ]
  },
  "151106_MM_21_02.raw": {
    "Source Name": [
      "MM_21"
    ],
    "Assay Name": [
      "151106_MM_21_02"
    ],
    "Raw Data File": [
      "151106_MM_21_02.raw"
    ],
    "Characteristics[NumberOfSamples]": [
      "111 lymph node metastasis samples from patients with malignant melanoma (Stage 3 and 4), archived in the local malignant melanoma biobank were obtained from Skåne University Hospital, Sweden."
    ],
    "Characteristics[Specimen]": [
      "Frozen tissue samples from BD20 were sectioned on a cryostat into 10\u2009\u00b5m thick slices (approximately 6\u00d76\u2009mm), placed into a 96 well plate and stored at \u221280\u2009\u00b0C until further use."
    ],
    "Characteristics[MaterialType]": [
      "Frozen specimens (snap frozen immediately after surgery)"
    ],
    "Characteristics[Disease]": [
      "malignant melanoma"
    ],
    "Characteristics[SpikedCompound]": [
      "The samples were spiked with 0.1\u2009mg of internal standard \u2013 chicken lysozyme (CL, Swiss-Prot accession no. P00698).",
      "20\u2009\u00b5L of samples were mixed with 20\u2009\u00b5L of peptide retention time calibration mixture (PRTC, Pierce/Thermo Scientific, Rockford, IL, 20 fmoL/mL)."
    ],
    "Characteristics[CleavageAgent]": [
      "sequencing grade trypsin (Promega, Madison, WI)"
    ],
    "Characteristics[ReductionReagent]": [
      "10\u2009mM DTT"
    ],
    "Characteristics[AlkylationReagent]": [
      "50\u2009mM iodoacetamide"
    ],
    "Comment[Instrument]": [
      "Thermo Easy nLC 1000 system (Thermo Fisher Scientific)",
      "Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)"
    ],
    "Comment[Separation]": [
      "Online chromatography was performed with a Thermo Easy nLC 1000 system (Thermo Fisher Scientific) coupled online to a Q-Exactive Plus mass spectrometer (Thermo Scientific, San Jos\u00e9, CA)."
    ],
    "Comment[FlowRateChromatogram]": [
      "Flow rate of 300 nL/min and a column temperature of 35\u2009\u00b0C were utilised."
    ],
    "Comment[GradientTime]": [
      "the gradient went from 5% to 40% B in the first 120\u2009min"
    ],
    "Comment[AcquisitionMethod]": [
      "data-dependent top-15 method"
    ],
    "Comment[FragmentationMethod]": [
      "fragmented in the HCD collision cell"
    ],
    "Comment[CollisionEnergy]": [
      "normalised collision energy of 30%"
    ],
    "Comment[MS2MassAnalyzer]": [
      "tandem mass spectra were acquired in the Orbitrap mass analyzer with resolution of 17 500 (at m/z 200), target AGC value of 1\u2212106 and maximum injection time of 120\u2009ms."
    ],
    "Comment[PrecursorMassTolerance]": [
      "20 ppm precursor tolerance"
    ],
    "Comment[FragmentMassTolerance]": [
      "0.02\u2009Da fragment tolerance"
    ],
    "Comment[NumberOfMissedCleavages]": [
      "Up to two missed cleavages for tryptic peptides was allowed."
    ],
    "Characteristics[Label]": [
      "Label-free LC-MS/MS analysis"
    ]
  }
}